about
In vivo assessment of safety of microneedle arrays in human skin.Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo.The caspase inhibitor zVAD increases lung inflammation in pneumovirus infection in miceTowards tailored vaccine delivery: needs, challenges and perspectives.Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases.Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.Neuropilin-1 Is Expressed on Lymphoid Tissue Residing LTi-like Group 3 Innate Lymphoid Cells and Associated with Ectopic Lymphoid AggregatesAn early innate response underlies severe influenza-induced exacerbations of asthma in a novel steroid-insensitive and anti-IL-5-responsive mouse model.Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method.Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications.Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation.Adjuvant effect of cationic liposomes and CpG depends on administration route.Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs.New insights into the function, development, and plasticity of type 2 innate lymphoid cellsIL-1β, IL-23, and TGF-β drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammationAdjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in miceCovalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccinationKLRG1 and NKp46 discriminate subpopulations of human CD117+CRTH2- ILCs biased toward ILC2 or ILC3Tregs in fibrosis: To know your enemy, you must become your enemy
P50
Q33355420-27C7EB80-808A-4989-BA1F-5398D7F2D06EQ33637958-06EF8A73-6BDB-4A1D-B8C1-5A5F998C4140Q35363216-47D41DC7-A714-4466-8385-9ED8A14D27D9Q37975885-BEBBE835-6ACE-4D73-A2D2-E8A1A66D624AQ38985676-EAF12D20-0080-4E9A-8723-0B6E2123C7D7Q39624231-69F44A40-FD80-4647-BC8C-048613A4BFE7Q40332169-55397D9D-937B-4E8B-8192-29B0C091FD51Q40519001-38A2E9F8-2E0A-4412-966F-40092C167537Q46659788-3DD6F8DC-E54E-4FD2-B62E-DE40A1260F82Q47307495-D9F6A6A9-A824-48C0-842C-F14B01530627Q47719552-7AC69D31-80F0-494F-95B9-DF7A03833D3DQ53258287-40DA7D0E-C423-4EBC-8028-4AA99ABC9974Q53268576-73F9E9CD-9CF0-4A9E-A716-08503B8CA73EQ53291828-86B24A1B-2275-4BFE-A66B-20D34C2F159FQ53311940-E94EBB26-7A7C-403B-AF5C-CBE25C635180Q53793238-52B8DA5A-87E5-48AD-A890-F25FEC39C815Q57181202-B6A7D488-FD3A-46E8-9EA6-628CD7CBF1E3Q64056484-A5F7DB10-B40D-4C1A-850C-EF866D8AF7CEQ82082523-94A8DC2D-8070-48D6-9903-DCB4A6EC354BQ84588291-DD637D45-24C9-4F2B-AAC3-2A91B1359115Q92760311-C178CB6D-1620-4900-9B1E-E3013D4CCEF3Q93160959-D065BBD5-31B8-4B03-8CFD-8023DFCD1170
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Suzanne Bal
@ast
Suzanne Bal
@en
Suzanne Bal
@es
Suzanne Bal
@nl
Suzanne Bal
@sl
type
label
Suzanne Bal
@ast
Suzanne Bal
@en
Suzanne Bal
@es
Suzanne Bal
@nl
Suzanne Bal
@sl
prefLabel
Suzanne Bal
@ast
Suzanne Bal
@en
Suzanne Bal
@es
Suzanne Bal
@nl
Suzanne Bal
@sl
P106
P108
P1153
15830994500
P21
P31
P496
0000-0002-3133-6450